Nordic Shares Decreased Thursday; BioGaia Series B Posted Biggest Loss
Nordic stocks fell Thursday, with the OMX Nordic 40 Index declining 0.7%.
BioGaia AB Series B posted the largest decline among large stocks during the session, declining 6.7%, followed by Volvo AB Series B shares, which declined 3.3%. Shares of Lifco AB Series B dropped 3.0%.
Embracer Group AB Series B was the biggest leader, surging 14.2%, and Vimian Group AB increased 8.3%. Marel hf. rounded out the top three leaders on Thursday, with shares adding 4.4%.
In Denmark, the Copenhagen Stock Exchange was closed, while the OMX Helsinki 25 Index, which tracks Finland's most-traded stocks, dropped 0.7%.
Stocks on Sweden's OMX Stockholm 30 Index fell 0.8%, while Norway's Oslo Exchange Benchmark Index_GI was flat at 1,328.15. Iceland's exchange, Nasdaq Iceland, was closed.
Elsewhere in Europe, indexes rose, with the STOXX Europe 600 Index rising 0.2% and the FTSE 100 Index rising 0.3% from the previous close.
Stock indexes in Asia were mixed, with Japan's NIKKEI 225 Index down 1.5% and China's Shanghai Composite Index up 0.6%.
In commodities news, Brent crude oil futures were up 1.4%, and gold futures were up 1.2%. Bitcoin rose 3.0% to $70,669.
On the currency front, the WSJ Dollar Index rose 0.1% to 99.04.
Against the euro, the U.S. dollar was up 0.3%, the Icelandic krona was flat, the Danish krone was flat, the Norwegian krone was down 0.4%, and the Swedish krona was down 0.5%.
Against the U.S. dollar, the Icelandic krona was down 0.2%, the euro was down 0.3%, the Danish krone was down 0.3%, the Norwegian krone was down 0.6%, and the Swedish krona was down 0.8%.
-This article was automatically generated by MarketWatch using technology from Automated Insights. Data source: Dow Jones Market Data, FactSet.
Write to Barcelona Editors at barcelonaeditors@dowjones.com
(END) Dow Jones Newswires
March 28, 2024 13:57 ET (17:57 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth